AP NEWS
Click to copy
Press release content from Business Wire. The AP news staff was not involved in its creation.
Click to copy
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Five Prime Therapeutics to Present at Two Upcoming Healthcare Conferences

May 24, 2019

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--May 24, 2019--

Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics today announced that Aron Knickerbocker, Chief Executive Officer, is scheduled to present at the following two investor conferences:

The presentations will be webcast and may be accessed at the “Events & Presentations” section of the Company’s website at: http://investor.fiveprime.com/events.cfm. Five Prime will maintain an archived replay of the webcast on its website for 30 days after the conference.

About Five Prime

Five Prime Therapeutics, Inc. discovers and develops innovative protein therapeutics to improve the lives of patients with serious diseases. Five Prime’s product candidates have innovative mechanisms of action and address patient populations in need of better therapies. The company focuses on researching and developing immuno-oncology and targeted cancer therapies paired with companion diagnostics to identify patients who are most likely to benefit from treatment with Five Prime’s product candidates. Five Prime has entered into strategic collaborations with leading global pharmaceutical companies and has promising product candidates in clinical and preclinical development. For more information, please visit  www.fiveprime.com  or follow us on  LinkedInTwitter  and  Facebook.

Source: Five Prime Therapeutics, Inc.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190524005408/en/

CONTACT: Media and Investor Contact

Martin Forrest

VP, Investor Relations & Corporate Communications

Five Prime Therapeutics, Inc.

415-365-5625

martin.forrest@fiveprime.com

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA COLORADO NEW YORK

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY CLINICAL TRIALS ONCOLOGY PHARMACEUTICAL

SOURCE: Five Prime Therapeutics, Inc.

Copyright Business Wire 2019.

PUB: 05/24/2019 04:01 PM/DISC: 05/24/2019 04:01 PM

http://www.businesswire.com/news/home/20190524005408/en

All contents © copyright 2019 The Associated Press. All rights reserved.